APA (7th ed.) Citation

HTM, N., ET, v. d. W., CJ, L., AB, T., PM, S., A, C., & C, V. (2024). Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits. British journal of pharmacology, 181(14), 2114. https://doi.org/10.1111/bph.15982

Chicago Style (17th ed.) Citation

HTM, Nguyen, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A, and Valant C. "Opportunities and Challenges for the Development of M1 Muscarinic Receptor Positive Allosteric Modulators in the Treatment for Neurocognitive Deficits." British Journal of Pharmacology 181, no. 14 (2024): 2114. https://doi.org/10.1111/bph.15982.

MLA (9th ed.) Citation

HTM, Nguyen, et al. "Opportunities and Challenges for the Development of M1 Muscarinic Receptor Positive Allosteric Modulators in the Treatment for Neurocognitive Deficits." British Journal of Pharmacology, vol. 181, no. 14, 2024, p. 2114, https://doi.org/10.1111/bph.15982.